LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | SU11274 | 3.33 | uM | LJP5 | 1 | J08 | 72 | hr | 1694 | 7399 | 11042 | 0.6701 | 0.7248 |
MCF 10A | SU11274 | 3.33 | uM | LJP5 | 2 | J08 | 72 | hr | 1694 | 7296 | 11099 | 0.6573 | 0.7133 |
MCF 10A | SU11274 | 3.33 | uM | LJP5 | 3 | J08 | 72 | hr | 1694 | 7764 | 11168 | 0.6952 | 0.7498 |
MCF 10A | SU11274 | 10 | uM | LJP5 | 1 | J07 | 72 | hr | 1694 | 5074 | 11042 | 0.4595 | 0.5002 |
MCF 10A | SU11274 | 10 | uM | LJP5 | 2 | J07 | 72 | hr | 1694 | 5240 | 11099 | 0.4721 | 0.5164 |
MCF 10A | SU11274 | 10 | uM | LJP5 | 3 | J07 | 72 | hr | 1694 | 5260 | 11168 | 0.4710 | 0.5165 |
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 1 | H12 | 72 | hr | 1694 | 9084 | 11220 | 0.8096 | 0.8509 |
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 2 | H12 | 72 | hr | 1694 | 8975 | 11309 | 0.7936 | 0.8381 |
MCF 10A | Canertinib | 0.04 | uM | LJP6 | 3 | H12 | 72 | hr | 1694 | 9266 | 11121 | 0.8332 | 0.8700 |
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 1 | H11 | 72 | hr | 1694 | 6375 | 11220 | 0.5681 | 0.6256 |
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 2 | H11 | 72 | hr | 1694 | 6064 | 11309 | 0.5362 | 0.5929 |
MCF 10A | Canertinib | 0.12 | uM | LJP6 | 3 | H11 | 72 | hr | 1694 | 7040 | 11121 | 0.6330 | 0.6900 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 1 | H10 | 72 | hr | 1694 | 4107 | 11220 | 0.3660 | 0.3835 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 2 | H10 | 72 | hr | 1694 | 4000 | 11309 | 0.3537 | 0.3684 |
MCF 10A | Canertinib | 0.37 | uM | LJP6 | 3 | H10 | 72 | hr | 1694 | 4659 | 11121 | 0.4189 | 0.4516 |
MCF 10A | Canertinib | 1.11 | uM | LJP6 | 1 | H09 | 72 | hr | 1694 | 2862 | 11220 | 0.2551 | 0.2119 |
MCF 10A | Canertinib | 1.11 | uM | LJP6 | 2 | H09 | 72 | hr | 1694 | 2409 | 11309 | 0.2130 | 0.1371 |
MCF 10A | Canertinib | 1.11 | uM | LJP6 | 3 | H09 | 72 | hr | 1694 | 2944 | 11121 | 0.2647 | 0.2257 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 1 | H08 | 72 | hr | 1694 | 2362 | 11220 | 0.2105 | 0.1296 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 2 | H08 | 72 | hr | 1694 | 2131 | 11309 | 0.1884 | 0.0873 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 3 | H08 | 72 | hr | 1694 | 2193 | 11121 | 0.1972 | 0.0997 |
MCF 10A | Canertinib | 10 | uM | LJP6 | 1 | H07 | 72 | hr | 1694 | 99 | 11220 | 0.0088 | -0.6470 |
MCF 10A | Canertinib | 10 | uM | LJP6 | 2 | H07 | 72 | hr | 1694 | 106 | 11309 | 0.0094 | -0.6365 |
MCF 10A | Canertinib | 10 | uM | LJP6 | 3 | H07 | 72 | hr | 1694 | 142 | 11121 | 0.0128 | -0.5988 |
MCF 10A | NVP-AEW541 | 0.04 | uM | LJP5 | 1 | E18 | 72 | hr | 1694 | 10857 | 11042 | 0.9832 | 0.9875 |